financetom
Business
financetom
/
Business
/
Microsoft to lay off around 3% of workforce in organization-wide cuts
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Microsoft to lay off around 3% of workforce in organization-wide cuts
May 26, 2025 7:05 AM

By Aditya Soni

May 13 (Reuters) - Microsoft ( MSFT ) said on Tuesday it

was laying off less than 3% of its workforce, or around 6,000

employees, as the technology giant looks to rein in costs while

funneling billions of dollars into its ambitious bet on

artificial intelligence.

The cuts will be across all levels and geographies and are

likely the largest since Microsoft ( MSFT ) laid off 10,000 employees in

2023. The company let a small number of staff go in January over

performance-related issues, but the new cuts are not related to

that, according to CNBC, which first reported the news.

Big Tech has been spending heavily on AI as they see the new

technology as a major growth engine, while slashing costs

elsewhere to safeguard profit margins. Google has also laid off

hundreds of employees in the past year, as it looks to control

costs and prioritize AI, media reports have said.

"We continue to implement organizational changes necessary

to best position the company for success in a dynamic

marketplace," a Microsoft ( MSFT ) spokesperson said on mail.

The company, which had 228,000 workers as of June last year,

regularly uses layoffs to prioritize staffing in its main focus

areas.

Tuesday's move comes weeks after Microsoft ( MSFT ) posted

stronger-than-expected growth in its cloud-computing business

Azure and blowout results in the latest quarter, calming

investor worries in an uncertain economy.

But the cost of scaling its AI infrastructure has weighed on

profitability, with Microsoft Cloud margins narrowing to 69% in

the March quarter from 72% a year ago.

Microsoft ( MSFT ) has earmarked $80 billion in capital spending this

fiscal year, with most of it aimed at expanding data centers to

ease capacity bottlenecks for artificial intelligence services.

D.A. Davidson analyst Gil Luria said the layoffs showed

Microsoft ( MSFT ) was "very closely" managing the margin pressure

created by its heightened AI investments.

"We believe that every year Microsoft ( MSFT ) invests at the current

levels, it would need to reduce headcount by at least 10,000 in

order to make up for the higher depreciation levels due to their

capital expenditures," he said.

(Reporting by Aditya Soni and Akash Sriram in Bengaluru;

Editing by Shinjini Ganguli, Anil D'Silva and Devika Syamnath)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
STAAR Surgical prelim Q3 sales beat estimates, boosted by deferred China shipment
STAAR Surgical prelim Q3 sales beat estimates, boosted by deferred China shipment
Oct 20, 2025
Overview * STAAR Surgical ( STAA ) Q3 preliminary net sales rise 6.9% yr/yr, beating analyst expectations * Sales growth driven by recognition of deferred China shipment * Lower new orders from China due to leaner inventory management Outlook * STAAR Surgical ( STAA ) did not provide specific future guidance in its press release Result Drivers * DEFERRED CHINA...
Market Chatter: Apple Faces China Antitrust Complaint Over App Store Practices
Market Chatter: Apple Faces China Antitrust Complaint Over App Store Practices
Oct 20, 2025
07:40 AM EDT, 10/20/2025 (MT Newswires) -- Apple ( AAPL ) is facing a complaint filed with China's market regulator alleging abuse of its market position by restricting app distribution and payments to its own iOS platform on iPhones and iPads, Reuters reported Monday. The report cited a lawyer as saying that a filing to China's State Administration for Market...
Glaukos Says Drug Treating Keratoconus Receives FDA Approval
Glaukos Says Drug Treating Keratoconus Receives FDA Approval
Oct 20, 2025
07:40 AM EDT, 10/20/2025 (MT Newswires) -- Glaukos ( GKOS ) said Monday its new drug application for Epioxa, a topical drug therapy for the eye disorder keratoconus, has been approved by the US Food and Drug Administration. The approval of the drug is based on results from two phase 3 pivotal trials of over 400 patients that achieved their...
Biopharma firm CorMedix's preliminary Q3 revenue beats estimates, raises FY guidance
Biopharma firm CorMedix's preliminary Q3 revenue beats estimates, raises FY guidance
Oct 20, 2025
Overview * CorMedix's preliminary Q3 2025 revenue beats expectations, driven by strong DefenCath utilization * Company raises FY 2025 revenue guidance to at least $375 mln * CorMedix ( CRMD ) expects $30 mln operating synergy before year-end 2025 Outlook * CorMedix ( CRMD ) raises FY 2025 pro forma net revenue guidance to at least $375 mln * Company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved